HPV and Other Risk Factors Involved in Pharyngeal Neoplasm—Clinical and Morphopathological Correlations in the Southwestern Region of Romania

Oropharyngeal squamous cell carcinoma (OPSCC) development is strongly associated with risk factors like smoking, chronic alcohol consumption, and the living environment, but also chronic human papilloma virus (HPV) infection, which can trigger cascade cellular changes leading to a neoplastic transformation. The prevalence of these factors differs among different world regions, and the prevention, diagnosis, and prognosis of OPSCC are highly dependent on them. We performed a retrospective study on 406 patients diagnosed with OPSCC in our region that were classified according to the tumor type, localization and diagnosis stage, demographic characteristics, risk factors, and histological and immunohistochemical features. We found that most of the patients were men from urban areas with a smoking habit, while most of the women in our study were diagnosed with tonsillar OPSCC and had a history of chronic alcoholism. During the immunohistochemical study, we analyzed the tumor immunoreactivity against anti-p16 and anti-HPV antibodies as markers of HPV involvement in tumor progression, as well as the correlation with the percentage of intratumoral nuclei immunomarked with the anti-Ki 67 antibody in serial samples. We observed that the percentage of Ki67-positive nuclei increased proportionally with the presence of intratumoral HPV; thus, active HPV infection leads to an increase in the rate of tumor progression. Our results support the implementation of strategies for OPSCC prevention and early diagnosis and can be a starting point for future studies aiming at adapting surgical and oncological treatment according to the HPV stage for better therapeutic results.

[1]  A. Madabhushi,et al.  Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration , 2022, Modern Pathology.

[2]  C. Fakhry,et al.  Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045. , 2021, JAMA oncology.

[3]  San-Gang Wu,et al.  Survival Outcomes and Treatment Decision by Human Papillomavirus Status Among Patients With Stage IVC Head and Neck Squamous Cell Carcinoma , 2021, Frontiers in Oncology.

[4]  E. Lengerich,et al.  Rural-urban differences in the association between individual, facility, and clinical characteristics and travel time for cancer treatment , 2020, BMC Public Health.

[5]  L. Alemany,et al.  Human papillomavirus-related oropharyngeal cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  N. Husain,et al.  Human papillomavirus associated head and neck squamous cell carcinoma: Controversies and new concepts. , 2017, Journal of oral biology and craniofacial research.

[7]  Alix Warburton,et al.  The role of integration in oncogenic progression of HPV-associated cancers , 2017, PLoS pathogens.

[8]  M. von Knebel Doeberitz,et al.  Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta‐analysis , 2017, International journal of cancer.

[9]  C. von Buchwald,et al.  Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population‐based study , 2016, International journal of cancer.

[10]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2012: a synthetic analysis. , 2016, The Lancet. Global health.

[11]  Xiaodong Zhou,et al.  Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes , 2015, Head & neck.

[12]  J. Gornbein,et al.  HPV-Positive Oropharyngeal Carcinoma , 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[13]  D. O’Connell,et al.  The effects of geography on survival in patients with oral cavity squamous cell carcinoma. , 2015, Oral oncology.

[14]  Junnian Zheng,et al.  Ki67 is a promising molecular target in the diagnosis of cancer (review). , 2015, Molecular medicine reports.

[15]  S. Sanjosé,et al.  HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. , 2014, The Lancet. Oncology.

[16]  D. Hartl,et al.  Oropharyngeal cancers: relationship between epidermal growth factor receptor alterations and human papillomavirus status. , 2014, European journal of cancer.

[17]  M. Rietbergen,et al.  Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  C. West,et al.  The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma. , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

[19]  T. Liloglou,et al.  Lung cancer epigenetics: emerging biomarkers. , 2013, Biomarkers in medicine.

[20]  S. Koontongkaew The Tumor Microenvironment Contribution to Development, Growth, Invasion and Metastasis of Head and Neck Squamous Cell Carcinomas , 2013, Journal of Cancer.

[21]  M. Pawlita,et al.  Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. , 2012, Cancer research.

[22]  E. Munck‐Wikland,et al.  Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer , 2012, Cancer medicine.

[23]  G. Pitiyage,et al.  Clinical and histopathologic parameters in survival of oral squamous cell carcinoma. , 2012, Oral surgery, oral medicine, oral pathology and oral radiology.

[24]  G. Botti,et al.  Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization , 2012, Infectious Agents and Cancer.

[25]  L. Stassen,et al.  A review of the relationship between alcohol and oral cancer. , 2011, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[26]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[27]  D. Rickman,et al.  Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma , 2010, International journal of cancer.

[28]  H. Morgenstern,et al.  Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. , 2010, International journal of epidemiology.

[29]  W. Ahrens,et al.  Active and Involuntary Tobacco Smoking and Upper Aerodigestive Tract Cancer Risks in a Multicenter Case-Control Study , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[30]  L. Notarangelo,et al.  X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. , 2009, Journal of autoimmunity.

[31]  S. Warnakulasuriya Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.

[32]  X. Castellsagué Natural history and epidemiology of HPV infection and cervical cancer. , 2008, Gynecologic oncology.

[33]  C. R. Leemans,et al.  A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen , 2007, International journal of cancer.

[34]  N. Coleman,et al.  Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis? , 2007, The Journal of pathology.

[35]  B. Migeon Why females are mosaics, X-chromosome inactivation, and sex differences in disease. , 2007, Gender medicine.

[36]  S. Franceschi,et al.  Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.

[37]  S. Tavtigian,et al.  Complex structure and regulation of the P16 (MTS1) locus. , 1995, Cancer research.

[38]  D. Carson,et al.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.

[39]  D. Kallogjeri,et al.  Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: a critical analysis of patterns and outcomes. , 2014, Oral oncology.

[40]  S. Tekade,et al.  Oxidative and antioxidative mechanisms in oral cancer and precancer: a review. , 2014, Oral oncology.

[41]  A. Garden,et al.  An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center , 2013, Cancer.

[42]  S. Franceschi,et al.  Biological activity of probable/possible high‐risk human papillomavirus types in cervical cancer , 2013, International journal of cancer.

[43]  Peter Boyle,et al.  Tobacco smoking and cancer: A meta‐analysis , 2008, International journal of cancer.